JPM
JPMorgan Chase & Co.
JPM has the edge over MSBI overall, supported by stronger valuation and lower modeled downside.
MSBI
Midland States Bancorp, Inc.
MSBI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MSBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MSBI's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MSBI.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over MSBI in the historical PE scenario, which offers more potential upside but is not a forecast.
MSBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $15.25 | -52% |
| Fair | 8.8x | $20.08 | -37% |
| Forward | 9.1x | $31.72 | — |
| Current | 14x | $31.72 | — |
| Expensive | 16x | $36.37 | +15% |
Historical ranges are pointers, not guarantees.
MSBI's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings, in its fair range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MSBI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
MSBI has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus MSBI up 14%.
MSBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.47 | +51% |
| Q3 2024 | $2.01 | -46% |
| Q2 2024 | $1.98 | -51% |
| Q1 2024 | $2.64 | -37% |
| Q4 2023 | $2.97 | -30% |
| Q3 2023 | $3.73 | -5.6% |
| Q2 2023 | $4.06 | +7.7% |
| Q1 2023 | $4.17 | +13% |
| Q4 2022 | $4.23 | +18% |
MSBI's earnings per share have fallen from their peak: $2.29 over the past year, against $4.23 in late 2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over MSBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MSBI on profitability, with a higher operating margin.
MSBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $86M | +5.9% |
| Q2 2026 | $83.4M | +1.4% |
| Q1 2026 | $79.5M | +4.6% |
| Q4 2025 | $85.6M | -8.9% |
| Q3 2025 | $81.1M | +9.2% |
| Q2 2025 | $82.2M | +13% |
| Q1 2025 | $76.1M | -1.4% |
| Q4 2024 | $93.9M | +31% |
MSBI's revenue grew through 2024 and has held roughly level since: $86M last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +20 points |
| Q2 2026 | 31% | +13 points |
| Q1 2026 | 30% | +212 points |
| Q4 2025 | -3.8% | +38 points |
| Q3 2025 | 14% | -16 points |
| Q2 2025 | 18% | +6.5 points |
| Q1 2025 | -181% | -205 points |
| Q4 2024 | -41% | -70 points |
MSBI's operating margin was 34% last quarter, up 20 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MSBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.9M | -52% |
| Q2 2026 | $29.2M | +9.5% |
| Q1 2026 | $16.3M | -28% |
| Q4 2025 | -$7.8M | -115% |
| Q3 2025 | $78.6M | +153% |
| Q2 2025 | $26.7M | +61% |
| Q1 2025 | $22.9M | -13% |
| Q4 2024 | $52.8M | -38% |
MSBI has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MSBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +65.5K shares |
| 1 year | -3.3% | -724K shares |
| 3 years | -3.8% | -837K shares |
| 5 years | -6.4% | -1.4M shares |
| Available history | -14% | -3.4M shares |
MSBI has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11,000 |
| Q2 2026 | $2.7M |
| Q1 2026 | $7.9M |
| Q4 2025 | $9.7M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $29,000 |
MSBI spent $20M buying back its own shares over the past year, more than ten times what it spent the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over MSBI on leverage, with a lower net debt burden relative to earnings.
MSBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 5.6x | High |
| Q4 2024 | 16.1x | High |
| Q3 2024 | 5.1x | High |
| Q2 2024 | 6.7x | High |
| Q1 2024 | 3.7x | Elevated |
| Q4 2023 | 4.0x | High |
MSBI's net debt is about 5.2 years of its operating earnings (EBITDA), about the same as a year ago. Net leverage isn't a meaningful measure for financial services companies like MSBI.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MSBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.6 | Neutral |
| Stochastic | 23.0 | Neutral |
MSBI's weekly RSI is 56 (neutral) and its Stochastic is 23 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MSBI PE vs Financial Services Sector
| Metric | MSBI | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6.4% above |
| PE % | 79 | 63 | 16 pts above |
MSBI has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MSBI on trend strength, trading above more of its moving averages.
MSBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.5 | 2.4% below |
| 20 week MA | $32.6 | 2.6% below |
| 50 week MA | $27.5 | 15% above |
| 100 week MA | $22.8 | 39% above |
| 200 week MA | $23.0 | 38% above |
MSBI has slipped below its 8- and 20-week averages, though it's still 38% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
MSBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.0 | $17.5 | -40% |
| 2021 | $17.5 | $25.0 | +43% |
| 2022 | $25.0 | $26.5 | +6.2% |
| 2023 | $26.5 | $27.6 | +3.9% |
| 2024 | $27.6 | $24.4 | -11% |
| 2025 | $24.4 | $21.2 | -13% |
| 2026 YTD | $21.2 | $31.7 | +50% |
MSBI has the edge over JPM on returns for 2026, with the stronger performance.